SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-12-004633
Filing Date
2012-04-24
Accepted
2012-04-24 09:10:07
Documents
3
Period of Report
2012-06-13
Effectiveness Date
2012-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2208455zdef14a.htm DEF 14A 550525
2 G18902BCI001.GIF g18902bci001.gif GRAPHIC 61071
3 G18902BCI002.GIF g18902bci002.gif GRAPHIC 37229
  Complete submission text file 0001047469-12-004633.txt   687490
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 12774668
SIC: 2835 In Vitro & In Vivo Diagnostic Substances